NMIMS Mumbai M.Pharm+MBA fees is 3,70,000 INR (Yearly) and goes up to 4,50,000 INR (Yearly) depending on the specialization. The average fees for the M.Pharm+MBA course is 3,90,000 INR (Yearly). NMIMS Mumbai M.Pharm+MBA admission 2024 will be based on GPAT, NMIMS NPAT.
Course | Duration | Fees |
M.Pharm+MBA- Industrial Pharmacy | 3 Years | 450000 INR |
M.Pharm+MBA-Pharmaceutical Quality Assurance | 3 Years | 370000 INR |
M. Pharm + MBA - Pharmaceutics | 3 Years | 370000 INR |
M.Pharm+MBA- Pharmaceutical Technology | 3 Years | 370000 INR |
The eligibility criteria for the M.Pharm. + M.B.A. degree at Narsee Monjee Institute of Management Studies Mumbai is a Bachelor's degree in Pharmacy (B.Pharm.) with a minimum of 50% aggregate marks from a recognized university. Candidates must also have a valid score in the NMIMS Management Aptitude Test (NMAT).
Admission to the M.Pharm+MBA at NMIMS Mumbai is subject to meeting the eligibility criteria and the candidates have to secure a valid score in GPAT, NMIMS NPAT. All shortlisted candidates have to complete the NMIMS Mumbai M.Pharm+MBA admission process by getting their documents verified and paying the admission fee.
NMIMS Mumbai M.Pharm+MBA application form has to be submitted online by visiting the official website. Candidates aspiring to take admission to the M.Pharm+MBA course at NMIMS Mumbai have to first check and meet the eligibility criteria and then proceed further with the application process.
According to the NMIMS Mumbai M.Pharm+MBA placement statistics, the average package for M.Pharm+MBA is 638000 INR.
The highest domestic package for NMIMS Mumbai M.Pharm+MBA is 638000 INR.
Specialization | Top Companies |
M. Pharm + MBA - Pharmaceutics | Cognizant, Cadila, Ernst & Young, ZS Associates, Glenmark Pharma, Stryker, Sun Pharma, Thermo Fisher Scientific, Zydus |
M.Pharm+MBA- Pharmaceutical Technology | Cognizant, Cadila, Ernst & Young, ZS Associates, Glenmark Pharma, Stryker, Sun Pharma, Thermo Fisher Scientific, Zydus |
M.Pharm+MBA-Pharmaceutical Quality Assurance | Cognizant, Cadila, Ernst & Young, ZS Associates, Glenmark Pharma, Stryker, Sun Pharma, Thermo Fisher Scientific, Zydus |
NMIMS Mumbai has secured 88 rank in 2023. Furthermore, NMIMS Mumbai ranking 2023 as per NIRF is 88. Securing a rank by these credible ranking bodies means the institute maintains certain academic standards and is a reputable one.